Budesonide Market Size, Share, Industry Growth & Forecast Analysis to 2027

Global Budesonide Market Size, Share, Growth, Industry Trends, Competitive Analysis and Forecast to 2030

Report ID: RC17625 | Report Format: PDF + Excel | Starting Price: 3800/- USD |

The global budesonide market size was is accounted to register a sustainable CAGR of 5.4% during the forecast period 2021 to 2027 and expected to reach at USD 4,260 million by 2027. Rising prevalence of pulmonary complication worldwide primarily drives the budesonide market growth. Additionally, positive results obtained from clinical trial investigation of budesonide in the treatment of inflammatory bowel disease further accentuates its market growth.

Budesonide is a small molecule which received USFDA approval in February 1994, it is basically a glucocorticoid molecule which is a mixture of 22R and 22S epimer which is currently being widely employed for the treatment of inflammation associated with lungs and gastrointestinal systems of the human body. It is currently available both as a generic drug and over the counter product (OTC) in different formulations such as metered sprays, nebulizers, inhalers, suspension, capsules etc.

Market Segment Insights:

Pulmonary complications are representing the largest market share in the clinical application segment for budesonide market. According to the latest research citings presented by the World Health Organization (WHO), approximately 339 million individuals throughout the globe are suffering with asthma. Constant rise in tobacco smoking, alarming increase in air pollution are associated with significant increase in the number of patients suffering with chronic obstructive pulmonary disease (COPD) worldwide. Inflammatory bowel disease is expected to register impressive market growth during the forecast period on account of the rising prevalence of ulcerative colitis and Crohn’s disease across the globe. In the last decade several clinical trial investigation has been conducted by various pharmaceutical companies to understand the therapeutic efficacy of budesonide in the treatment of inflammatory bowel disease and has been reported to deliver positive results in the 3 months maintenance of remission of Crohn’s disease.

Budesonide Market Size and Forecast

To know more about the study, request a report sample

Hospital pharmacist is presently reigning the distribution channel segment for budesonide market. Different dose strength of budesonide formulation are prescribed by physicians for treating patients suffering with pulmonary complications hence, accurate dispensing of budesonide by a hospital pharmacist is necessary to prevent occurrence of any unwanted drug toxicity. Retail pharmacy is gaining tremendous popularity as a distribution channel in the developing regions on account of the presence of well-established generic drugs market and flourishing over the counter products (OTC) market.

The budesonide comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2020 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The budesonide market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

2018-19 – Historical Year
2020 – Base Year
2021-2027 – Forecast Period

Global Budesonide Market Segmentation:

By Clinical Application:

Pulmonary Complications
Inflammatory Bowel Disease
Others

By Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Others

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Geographic Coverage:

North America is presently spearheading the geography segment for budesonide market. Rising prevalence of asthma and allergic rhinitis together drive the budesonide market growth in the region. As per the latest research citings provided by the Center for Disease Control and Prevention (CDC), approximately 25 million U.S. citizens are suffering with asthma. Presence of a well-developed healthcare infrastructure and affordable reimbursement scenario together propel the market growth in the region. Europe is the second largest regional segment for budesonide market. Growing incidence of inflammatory bowel disease determines the market growth in the region. Furthermore domicile of major players such as Novartis AG, Chiesi Farmaceutici S.p.A., Boehringer Ingelheim AG etc. further accentuate the market growth in the region. Asia Pacific is anticipated to be the fastest growing regional segment for budesonide market on account of the rising prevalence of chronic obstructive pulmonary disease (COPD) and flourishing over the counter budesonide products market.

Market Competition Assessment:

Key players operating in the global budesonide market are AstraZeneca, Plc., Teva Pharmaceutical Industries Limited., Cipla Limited, Mylan Pharmaceutical Industries Limited., and Novartis AG. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

AstraZeneca, Plc.
Teva Pharmaceutical Industries Limited
Mylan Pharmaceutical Industries Limited
Apotex Corporation
Cipla Limited
Novartis AG
Orion Pharma
Boehringer Ingelheim AG
Falk Pharma
Chiesi Farmaceutici S.p.A.

Key Questions Answered by Budesonide Market Report:

Global budesonide market forecasts from 2021-2027
Regional budesonide market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
Budesonide submarket forecasts from 2021-2027 covering the market by clinical application, by distribution channel, and geography
Various industry models such as SWOT analysis, Value Chain Analysis pertaining to budesonide market
Analysis of the key factors driving and restraining the growth of the global, regional and country-level budesonide markets from 2021-2027
Competitive Landscape and market positioning of top 10 players operating in the budesonide market

Table of Content:

Chapter 1. Introduction

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Scope
1.3.1. Market Segmentation
1.3.2. Years Considered for the Study
1.4. Currency
1.5. Limitation
1.6. Market Stakeholders

Chapter 2. Research Methodology

2.1. Market Size Estimation
2.2. Market Breakdown and Data Triangulation
2.3. Market Share Estimation
2.4. Key Data From Secondary Sources
2.5. Key Data From Primary Sources
2.6. Key Industry Insights
2.7. Assumptions for the Study

Chapter 3. Executive Summary

3.1. Global Budesonide Market Snapshot
3.2. Global Budesonide Market, by Clinical Application, 2020 (US$ Mn)
3.3. Global Budesonide Market, By Distribution Channel, 2020 (US$ Mn)
3.4. Global Budesonide Market, by Geography, 2020 (US$ Mn)

Chapter 4. Budesonide Market: Dynamics and Future Outlook

4.1. Market Overview
4.2. Drivers
4.3. Challenges
4.4. Opportunities
4.5. Attractive Investment Proposition, by Geography, 2020

Chapter 5. Global Budesonide Market, by Clinical Application

5.1. Introduction
5.2. Pulmonary Complication
5.3. Inflammatory Bowel Disease
5.4. Others

Chapter 6. Global Budesonide Market, By Distribution Channel

6.1. Introduction
6.2. Hospital Pharmacy
6.3. Retail Pharmacy
6.4. Others

Chapter 7. Global Budesonide Market, by Geography

7.1. Introduction
7.1. North America Budesonide Market Analysis, 2017 – 2027
7.1.1. North America Budesonide Market, by Clinical Application, 2017 – 2027 (US$ Mn)
7.1.2. North America Budesonide Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.1.3. North America Budesonide Market, by Country, 2017 – 2027 (US$ Mn)
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe Budesonide Market Analysis, 2017 – 2027
7.2.1. Europe Budesonide Market, by Clinical Application, 2017 – 2027 (US$ Mn)
7.2.2. Europe Budesonide Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.2.3. Europe Budesonide Market, by Country, 2017 – 2027 (US$ Mn)
7.2.3.1. U.K.
7.2.3.2. Germany
7.2.3.3. Russia
7.2.3.4. France
7.2.3.5. Italy
7.2.3.6. Spain
7.2.3.7. Ukraine
7.2.3.8. Rest of Europe
7.3. Asia Pacific Budesonide Market Analysis, 2017 – 2027
7.3.1. Asia Pacific Budesonide Market, by Clinical Application, 2017 – 2027 (US$ Mn)
7.3.2. Asia Pacific Budesonide Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.3.3. Asia Pacific Budesonide Market, by Country, 2017 – 2027 (US$ Mn)
7.3.3.1. China
7.3.3.2. Japan
7.3.3.3. Rest of Asia Pacific
7.4. Latin America Budesonide Market Analysis, 2017 – 2027
7.4.1. Latin America Budesonide Market, by Clinical Application, 2017 – 2027 (US$ Mn)
7.4.2. Latin America Budesonide Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.4.3. Latin America Budesonide Market, by Country, 2017 – 2027 (US$ Mn)
7.4.3.1. Brazil
7.4.3.2. Mexico
7.4.3.3. Rest of Latin America
7.5. Middle East and Africa Budesonide Market Analysis, 2017 – 2027
7.5.1. MEA Budesonide Market, by Clinical Application, 2017 – 2027 (US$ Mn)
7.5.2. MEA Budesonide Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.5.3. MEA Budesonide Market, by Country/Region, 2017 – 2027 (US$ Mn)
7.5.3.1. GCC
7.5.3.2. Rest of MEA

Chapter 8. Company Profiles

8.1. AstraZeneca, Plc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Recent Developments
8.1.5. SWOT Analysis
8.2. Teva Pharmaceutical Industries Limited
8.3. Mylan Pharmaceutical Industries Limited
8.4. Apotex Corporation
8.5. Cipla Limited
8.6. Novartis AG
8.7. Orion Pharma
8.8. Boehringer Ingelheim AG
8.9. Dr. Falk Pharma
8.10. Chiesi Farmaceutici S.p.A.

To know more about the study, request a report sample

List of Figures:

FIG. 1 Budesonide: Market Segmentation
FIG. 2 Global Budesonide Market, by Clinical Application, 2019 (US$ Mn)
FIG. 3 Global Budesonide Market, By Distribution Channel, 2019 (US$ Mn)
FIG. 4 Global Budesonide Market, by Geography, 2019 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2019
FIG. 6 Global Pulmonary Complications Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 7 Global Inflammatory Bowel Disease Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 8 Global Other Clinical Application Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 9 Global Hospital Pharmacy Market for Budesonide, 2017 – 2027 (US$ Mn)
FIG. 10 Global Retail Pharmacy Market for Budesonide, 2017 – 2027 (US$ Mn)
FIG. 11 Global Other Distribution Channel Market for Budesonide, 2017 – 2027 (US$ Mn)
FIG. 12 U.S. Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 13 Canada Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 14 U.K. Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 15 Germany Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 16 Russia Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 17 France Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 18 Italy Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 19 Spain Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 20 Ukraine Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 21 Rest of Europe Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 22 China Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 23 Japan Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 24 Rest of Asia Pacific Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 25 Brazil Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 26 Mexico Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 27 Rest of Latin America Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 28 GCC Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 29 Rest of MEA Budesonide Market, 2017 – 2027 (US$ Mn)
FIG. 30 Budesonide Market: Research Methodology

To know more about the study, request a report sample

List of Tables:

TABLE 1 Global Budesonide Market Snapshot
TABLE 2 Global Budesonide Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 3 Global Budesonide Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 4 Global Budesonide Market, by Geography, 2017 – 2027 (US$ Mn)
TABLE 5 North America Budesonide Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 6 North America Budesonide Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 7 North America Budesonide Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 8 Europe Budesonide Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 9 Europe Budesonide Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 10 Europe Budesonide Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 11 Asia Pacific Budesonide Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 12 Asia Pacific Budesonide Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 13 Asia Pacific Budesonide Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 14 Latin America Budesonide Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 15 Latin America Budesonide Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 16 Latin America Budesonide Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 17 Middle East and Africa Budesonide Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 18 Middle East and Africa Budesonide Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 19 Middle East and Africa Budesonide Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 20 AstraZeneca, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 21 Teva Pharmaceutical Industries Limited.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 22 Mylan Pharmaceutical Industries Limited.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 23 Apotex Corporation.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 24 Cipla Limited.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 25 Novartis AG.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 26 Orion Pharma: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 27 Boehringer Ingelheim AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 28 Dr. Falk Pharma: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 29 Chiesi Farmaceutici S.p.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)

Fill the given form to inquiry before buying for Budesonide Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample

Inquiry Before Buying

Schedule a Call

Select License Type

$ 3800/- Single User License
$ 5200/- Multi User License
$ 6995/- Corporate License